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Abstract
 
Several arguments suggest that minimal change nephrotic syndrome (MCNS) results from yet
unknown systemic disorder of T cell function. By screening a cDNA library from T cell relapse,
we identified a new pleckstrin homology (PH) domain-containing protein encoded by a gene
located on chromosome 16q24. Two alternative transcripts were identified. The first species
(c-mip) was expressed in fetal liver, kidney, and peripheral blood mononuclear cells (PBMCs),
but weakly detected in PBMCs from MCNS patients. The second form (Tc-mip, standing for
truncated c-maf inducing protein), corresponds to subtracted transcript and lacks the NH
 
2
 
-terminal
PH domain. The expression of Tc-mip was restricted to fetal liver, thymus, and MCNS
PBMCs where it was specifically recruited in CD4
 
 
 
 T cells subset. Overexpression of Tc-mip
in T cell Jurkat induced c-maf, transactivated the interleukin 4 gene and down-regulated the
interferon 
 
 
 
 expression, characteristic of a Th2 commitment. Moreover, the overexpression of
Tc-mip induced Src phosphorylation, T cell clustering, and a cellular redistribution of the
cytoskeleton-associated L-plastin, by a PI3 kinase independent pathway. Tc-mip represents
therefore the first identified protein, which links proximal signaling to c-maf induction.
Key words: lipoid nephrosis • T lymphocytes • pleckstrin domain • signal transduction
 
Introduction
 
Minimal change nephrotic syndrome (MCNS) is the most
frequent glomerular disease in children, characterized by
heavy proteinuria with relapse and remission courses (1).
Although no immune cell infiltration, or immune complex
deposit could be identified in the kidney, many arguments
suggest that MCNS results from a systemic disorder of T
cell function (2). Indeed, relapses often occur in the con-
text of immune challenge initiated by infectious, allergic
stimuli or vaccine and they are usually sensitive to drugs
known to inhibit the immune system (glucocorticoids, cy-
closporine, and cyclophosphamide). Nonetheless, the link
between immune disorders and this glomerular disease re-
mains unresolved.
Recently, we have shown that T lymphocytes from
MCNS were rather driven toward a Th2 phenotype. Sup-
porting this view, we found that T cells display a down-
regulation of the IL-12 receptor 
 
 
 
2 subunit (IL-12R 
 
 
 
2),
whereas the second component of the IL-12R, the 
 
 
 
1
chain, was normally expressed (3). The IL-12R 
 
 
 
2 is selec-
tively expressed by Th1 cells and plays a key role in the
transduction of IL-12 signaling through the Jak/Stat pathway.
The down-regulation of the IL-12R 
 
 
 
2 is compatible with
a lack of IL-12 production during relapse (4). The commit-
ment of MCNS T cells along the Th2 pathway involves the
recruitment of c-maf of which the functional expression
appears closely related to MCNS activity (unpublished
data). It has been shown that c-maf promotes T helper cell
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Abbreviations used in this paper:
 
 MCNS, minimal change nephrotic syn-
drome; PKC, protein kinase C; Tc-mip, truncated c-maf inducing protein.T
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type 2 (Th2) and attenuates Th1 differentiation (5, 6). As a
matter of fact, patients with MCNS are often unable to
mount an effective Th1 response that might account for
observed defects in delayed-type hypersensitivity response
and recall response to antigens (2, 7).
To understand in depth the molecular mechanisms in-
volved in this T cell dysfunction, we recently identified by
subtractive cloning and differential screening, transcripts
up-regulated during the active phase of the disease (3).
Among them, we isolated a truncated form of a new pro-
tein, involved in c-maf signaling pathway, that we named
Tc-mip (for truncated c-maf inducing protein). The natu-
ral transcript, c-mip, corresponds to the product of the
Kiaa1694 gene, previously identified in the human brain
(8). Tc-mip exhibited a deletion within the NH
 
2
 
-terminal
pleckstrin homology domain (PH) of c-mip and its tran-
script is selectively induced in active phase of the disease
whereas it is hardly detected in T cells of normal subjects.
We show here that overexpression of Tc-mip in Jurkat T
cells, strongly induces the c-maf protein and increases the
IL-4 promoter-mediated transcription, whereas it concom-
itantly represses the IFN-
 
 
 
 expression. Moreover, overexpres-
sion of Tc-mip in Jurkat T cells, induces T cell clustering
and cellular redistribution of L-plastin, a cytoskeleton-asso-
ciated protein, by a PI3 kinase–independent pathway.
These results suggest that Tc-mip plays a critical role in
Th2 signaling pathway and represents the first proximal sig-
naling protein which links TCR-mediated signal to the ac-
tivation of c-maf Th2 specific factor.
 
Materials and Methods
 
Patients.
 
The cohort of patients analyzed in this study has
been described previously (3, 9). In children, the criteria of the
International Study of Kidney Diseases were used for diagnosis
and management of MCNS (10). In adults, the diagnosis of
MCNS or Membranous Nephropathy (MN) was confirmed by
renal biopsy before inclusion. All patients with relapse (children
and adults) had proteinuria over 3 g/24 h, and low serum albu-
min levels (below 3 g/dl), at the time of blood sampling, which
was performed before the beginning of steroid treatment.
Remission samples were collected during periods of inactive
disease, defined by a proteinuria below 0.2 g/24 h. Controls con-
sisted of normal children studied while undergoing routine analy-
sis, normal adult volunteers, as well as patients with MN.
Informed consent was obtained from the parents and when-
ever possible from the pediatric patients, as well as from adult pa-
tients and normal volunteers.
 
Antibodies and Reagents.
 
Immunoselection of T cell subsets
and monocytes was performed using a cocktail of hapten-conju-
gated antibodies (Miltenyi Biotech).
A polyclonal antibody common to c-mip and Tc-mip was
produced against a peptide of 15 aa, corresponding to amino ac-
ids 194–209 of the c-mip/Tc-mip (Eurogentec). Antibodies
against c-maf (sc-7866) and phospho Akt (ser-473) were pur-
chased from Santa Cruz Biotechnology Inc. and New England
Biolabs, Inc., respectively. Monoclonal antibody of L-Plastin
(Anti-LPLA4.1) was a gift of Drs. Eric J. Brown and Hua Shen
(University of California, San Francisco, CA) and was used at 1
 
 
 
g/ml. Wortmanin was purchased from Sigma-Aldrich). Anti-
phospho Src family (Tyr416) antibody was purchased from New
England Biolabs, Inc.
 
Purification of PBMC and T Cell Subsets.
 
PBMCs and T cell
subsets were purified as described previously (9). The purity of
the preparations was 88–96%, as assessed by flow cytometric anal-
ysis, using FITC-conjugated CD2, CD4
 
 
 
, CD19, and CD8 anti-
bodies. Activation was performed with 5 
 
 
 
g/ml PMA (phorbol
ester myristate) and 5 
 
 
 
g/ml calcium ionophore (ionomycin), for
4 h. Th1 and Th2 polarized T cells were a gift of Dr. Pellegrini
(Institut Pasteur, Paris, France).
 
Immunocytochemistry.
 
Cells were cytospun at 10
 
5
 
 cells/slide,
fixed and permeabilized by using methanol at –20
 
 
 
C, then pro-
cessed for immunoreactivity. Cells were incubated in the block-
ing solution (10% normal sheep serum (NSS), 1% BSA for 40
min, washed twice with PBS, then incubated with Tc-mip (1/
200) or L-plastin (1 
 
 
 
g/ml) antibody (in 5% NSS, 1% BSA, 0.1%
Tween 20) for 2 h at room temperature. Slides were washed
three times with PBS, then incubated with anti–rabbit Cy3-
labeled antibody (1/1,000 in blocking solution) for 30 min. Slides
were mounted in a Vectashield DAPI (Vector Laboratories), and
analyzed on an Axioplan Zeiss microscope equipped for epifluo-
rescence. The percentage of positive cells was determined on an
average of 200 cells.
 
RT-PCR.
 
Total RNAs were treated by DNase I and purified
using Rneasy kit (QIAGEN), following the supplier’s protocol.
The 5
 
 
 
 and 3
 
 
 
 primers of Tc-mip and c-mip were selected in the
first respective exon. The sequence of the primers, and PCR pa-
rameters are indicated in Table I.
Semiquantitative RT-PCR was performed as previously re-
ported (9). Each cycle consists of denaturation at 94
 
 
 
C for 30 s,
annealing at the indicated temperature for 30 s and extension at
68
 
 
 
C for 2 min. Amplified products were detected on Southern
blots with [
 
32
 
P] labeled specific internal oligonucleotide probes
and quantified by using a PhosphorImager (Storm 840, Molecular
Dynamics SA), coupled to the ImageQuant v1.11 analysis soft-
ware. PCR reactions were normalized for GAPDH expression.
 
Northern Blot.
 
Human multiple-tissue Northern blots (CLON-
TECH Laboratories, Inc.) were hybridized with a 560 bp cDNA
probe common to c-mip and Tc-mip or with a Tc-mip specific
probe corresponding to the first exon of Tc-mip. Hybridiza-
tion and blot processing were performed as described pre-
viously (3).
 
DNA Sequencing.
 
Preparation and sequencing of double
stranded plasmid DNA template and sequencing were performed
as reported previously (3). Nucleic acid and protein database
searches were done using resources of the National Center Bio-
technology Information.
 
Western Blots and Electromobility Shift Assays.
 
Preparation and
quantification of protein extracts, as well as SDS-PAGE immuno-
blotting, and electromobility shift assay (EMSA) experiments,
were performed as described previously (9). The double-stranded
oligonucleotide probes (100 ng; Genset), consisting of the wild
(5
 
 
 
-GGAATTGCTGACTCAGCATTACT-3
 
 
 
) and the mutant
(5
 
 
 
-GGAATTGCTGACTCATTGTTACT-3
 
 
 
) MAREs con-
taining the c-Maf recognition sequence (underlined). The speci-
ficity of band shift was also tested by preincubation of nuclear ex-
tracts with 2 
 
 
 
g of polyclonal antibodies raised against c-maf.
 
Cloning of the 5
 
  
 
End of c-mip by Rapid Amplification of cDNA
Ends (RACE).
 
Additional sequence upstream of the 5
 
 
 
end of
the c-mip mRNA was explored by using the 5
 
 
 
/3
 
 
 
RACE kit
(CLONTECH Laboratories, Inc.) and a universal antisense
primer included in the kit and a 28 mer antisense oligonucleotide
located at the position 145–172 of the c-mip-exon 1 (5
 
 
 
-GCT-T
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GAGAAAGGTCCGCGGGTGCCGGATG-3
 
 
 
). The PCR pro-
duct was blunt ended and cloned into Topo Zero blunt end
vector (Invitrogen), according to manufacturer’s protocol. Prepa-
ration and sequencing of double stranded plasmid DNA template
and sequencing were performed as described previously (3).
 
Plasmids Construction.
 
The cDNA corresponding to the cod-
ing sequences of Tc-mip and c-mip were obtained by RT-PCR
using PBMC RNA from a patient with MCNS relapse and a
normal subject, respectively. The specific primers are reported in
Table I. The amplified products were subcloned into pcDNA3.1/
V5-His TOPO cloning vector (Invitrogen). Chloramphenicol
acetyltransferase (CAT)-based human IL-4T promoter construct
was a gift of Dr. V. Casolaro (Johns Hopkins University School
of Medicine; reference 11).
 
Transient Transfections.
 
Jurkat T cells were obtained from the
American Type Culture Collection. Cells were grown in RPMI
1640 supplemented with 10% FCS. Transient transfections were
performed by electroporation of 30 
 
 
 
 10
 
6
 
 cells with 30 
 
 
 
g of each
plasmid (Tc-mip, c-mip, or empty vector), or in combination
with 10 
 
 
 
g of CAT-IL4-reporter construct, using a Bio-Rad Lab-
oratories Gene Pulser set at 250V and 960 
 
 
 
F. The transfected
cells were allowed to recover overnight, then were divided into
identical aliquots in 24-well plates. One aliquot was left unstimu-
lated whereas the other was stimulated with OKT3 ascite fluid
(1:5,000) for 6 h. In some experiments, wortmanin (100 nM) was
added to the culture medium 6 h following transfection and left
overnight. CAT assays were performed according to the manufac-
turer’s protocol (Promega). CAT activities, normalized by protein
content, were determined using a liquid scintillation counting as-
say (Packard Instrument Co.), and were shown as fold induction
relative to control, between stimulated and unstimulated condi-
tions. Efficiency of transfection was controlled by Western blot-
ting of cytosolic extracts, using the anti-c-mip/Tc-mip antibody.
 
Results
 
1-Identification and Characterization of Tc-mip.
 
A Tc-mip
cDNA clone (4.1kb, GenBank/EMBL/DDBJ accession
no.: AY172689) was isolated by differential screening of a
full length cDNA library, generated from T cell-enriched
PBMCs of MCNS relapse, using subtracted probes from
relapse versus remission (unpublished data). The Tc-mip
mRNA corresponds to an alternative species of c-mip (4.2
kb), isolated from human brain (8). Both Tc-mip and
c-mip are transcribed from a single gene comprising 21 ex-
ons spanning 268 Kb in length and located on chromo-
some 16q24 (Fig. 1). A Tc-mip 5
 
 
 
 RACE did not reveal
upstream 5
 
 
 
 sequence in c-mip and Tc-mip (data not de-
picted), suggesting that both mRNA are transcribed from
distinct promoter regions.
The Tc-mip and c-mip cDNAs contain an open reading
frame of 2040 and 2220 nucleotides, encoding 679 (75 kD)
and 739 (85 kD) amino acid proteins respectively. Both
initiation codons (ATG) are flanked by the Kozak consen-
sus sequence. The c-mip protein contains a pleckstrin ho-
mology (PH) domain encoded by exons 1, 2, 3, and 4. The
 
Table I.
 
Sets of Primers Used in Semiquantitative RT-PCR and for PCR Amplification of Coding Sequences of c-mip and Tc-mip
 
mRNA Oligonucleotides Accession no.
Expected size
(bp)
Tm annealing
(
 
 
 
C) PCR cycles
GAPDH S: 5
 
 
 
-
 
ACCACAGTCCATGCCATCAC
 
-3
 
 
 
AS: 5
 
 
 
-
 
TCCACCACCCTGTTGCTGTA
 
-3
 
 
 
I: 5
 
 
 
-
 
CTCAAGGGCATCCTGGGCTACACTGAGCAC
 
-3
 
 
 
NM 004048 374 58 25
c-maf S: 5
 
 
 
-
 
TGCACTTCGACGACCGCTTCTC
 
-3
 
 
 
 
AS: 5
 
 
 
-
 
CGCTGCTCGAGCCGTTTTCTC
 
-3
 
 
 
AF055376 326 62 32
Tc-mip S: 5
 
 
 
-
 
CCTGCGAGGAGGGAAGTTACAGATCTC
 
-3
 
 
 
AS: 5
 
 
 
-
 
CAGGTAGCTATTGGCAGCCTGCAGTAAG
 
-3
 
 
 
I: 5
 
 
 
-
 
ATGGGACAGGCTGCTGAGCCAACT
 
-3
 
 
 
AY172689
209 62 32
c-mip S: 5
 
 
 
-
 
GAAGGCACGAAGATGGGCGCCGTGCCCT
 
-3
 
 
 
 
AS:5
 
 
 
-
 
GCTGAGAAAGGTCCGCGGGTGCCGGATG
 
-3
 
 
 
 
ABO51481 130 75 32
IL-4 S:5
 
 
 
-
 
TTCTCCTGATAAACTAATTGCCTCACATTGTC
 
-3
 
 
 
AS:5
 
 
 
-
 
GGTGATATCGCACTTGTGTCCGTGG
 
-3
 
 
 
XM004053 143 60 34
IFN-
 
 
 
S: 5
 
 
 
-
 
GGTTCTCTTGGCTGTTACTGC-3 
AS: 5 -GTCATCTCGTTTCTTTTTGTTGCT-3 
XM006883 294 60 34
Tc-mip (CS) S: 5 -ATGGGACAGGCTGCTGAGCCAA-3 
AS: 5 -CTTCCTGCCTTGAGCTGGGAGC-3 
AY172689 2150 63 32
c-mip (CS) S: 5 -ATGGGCGCCGTGCCCT-3 
AS: 5 -CTTCCTGCCTTGAGCTGGGAGC-3 
ABO51481 2270 56 32
The oligonucleotides sense (S) and antisense (AS) were selected from the sequences with the indicated accession numbers. The size of each amplified
product, annealing temperature of each oligonucleotide, and the number of PCR cycles are indicated. I, internal oligonucleotide probe; CS, coding
sequence.T
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PH domain starts at position 38 of exon 1 that encodes 66
amino acids. The Tc-mip transcript does not contain the
first exon of c-mip but starts with a new 145 nucleotide-
exon, encoding 6 amino acids and which is located 50 Kb
downstream of c-mip-exon 1 on the genome (Fig. 1 A).
Thus, Tc-mip exhibits a different amino-terminal part, as
compared with c-mip, characterized by an NH2-terminal
truncation of 29 aa within the pleckstrin homology (PH)
domain. This change does not modify the reading frame of
the remainder of the protein that is identical in both pro-
teins but alters the spatial configuration of the PH domain
by deletion of the   sheet 1, the   sheet 2, and the loop
 1 2 (Fig. 1 B). Beside the PH domain, Tc-mip and
c-mip proteins contain a leucine-rich repeat (LRR) do-
main encoded by the exon 19. The remainder of the
protein does not exhibit significant homology with others
known domains but contains several patterns, including
protein kinase C (PKC), casein kinase II, and tyrosine, po-
tential phosphorylation sites. The truncation of Tc-mip re-
moves the putative Thr 61, Ser 62, and Lys 63 PKC phos-
phorylation sites as compared with c-mip.
We hybridized multiple-tissue Northern blots with a
cDNA probe common to Tc-mip and c-mip (Fig. 2, top
panel). We only detected a signal at 4.25 kb corresponding
to c-mip mRNA. The transcript was highly expressed in
PBMCs, kidney, and fetal liver and to a lesser extent in
adult brain and liver. On the other hand, the Tc-mip spe-
cific probe (corresponding to proximal 5 -145 nucleotides
of Tc-mip) only hybridized with mRNA originating from
thymus and fetal liver (Fig. 2, bottom panel). We were not
able to make a Northern blot of Tc-mip transcript in
PBMC of MCNS patients because of the scarcity of the bi-
ological material.
2-Expression of Tc-mip in Resting and Activated T Cells.
As Northern-blot analyses revealed a basal expression of
c-mip in PBMCs, we analyzed by semiquantitative RT-
Figure 1. Comparative structure of c-mip and Tc-mip. (A) Genomic structure of c-mip and Tc-mip. Exons are depicted as numbered boxes and in-
trons are not drawn to scale. Dashed boxes indicate identical exons. Between gene structures are representation of transcript products. Protein structure
was analyzed by Smart software (Simple Modular Architecture Research Tool), which detected the PH domain (encoded by exons 1, 2, 3, and 4 and the
Leucine-rich repeats (LRR), encoded by the exon 19). Both transcripts differ by use of the first exon indicated by a striped box: c-mip exon 1 encodes
for 66 amino acid (aa) of which the 29 aa COOH-terminal (position 38–66) contribute to PH domain (109 aa); Tc-mip exon-1 encodes for 6 aa outside
of the PH domain (80 aa). (B) Prediction of   sheet structures of the PH domain using the Garnier Peptide structure tools (http://biotools.umassed.edu/
cgi-bin/biobin/garnier). Amino acid sequence corresponding to the PH domain is indicated in bold characters.
Figure 2. Northern blot anal-
ysis of c-mip and Tc-mip. (Top
panel) Multiple tissue-Northern
blots (CLONTECH Laborato-
ries, Inc.) were hybridized with a
560-bp cDNA probe common
to Tc-Mip and c-Mip and ex-
posed on a PhosphorImager
Storm for 24 h. BM, bone mar-
row; B, brain; H, heart; SK,
skeletal muscle; C, colon; T,
thymus; S, spleen; K, kidney; L,
liver; I, intestine; P, placenta; Lu,
lung. (Bottom panel) Expression
pattern of Tc-mip, using cDNA
probe encoded by the Tc-mip
exon-1.T
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PCR, the relative expression of Tc-mip and c-mip mRNA
in PBMC subsets purified by immunomagnetic selection.
In resting cells, we found that the c-mip transcript was ex-
pressed in monocytes, CD8 , CD4  T cells, and B lym-
phocytes, whereas the Tc-mip transcript was detected at
lower levels only in CD4  and CD8  T cells (Fig. 3 A).
To determine whether these transcripts are induced in re-
sponse to activating conditions, cells were exposed to phor-
bol ester myristate (PMA) and calcium ionophore (iono-
mycin), for 4 h. The expression of c-mip and Tc-mip
mRNAs was markedly down-regulated in activated cells
(Fig. 3 A). Then we analyzed the protein expression by im-
munoblotting with a polyclonal antibody recognizing the
amino acid sequence 194–209 common to Tc-mip and
c-mip proteins. Contrasting with their basal mRNA ex-
pression, we were unable to detect Tc-mip by immuno-
blotting, whereas c-mip was very faintly or not detected,
either in resting or in activated cells (unpublished data),
suggesting post transcriptional regulation mechanisms. As
the expression of c-mip and Tc-mip felt in normal T cells
activated by PMA and CA2 ionophore (Fig. 3 A), we
sought to determine whether such effects could be also ob-
served in T cells from MCNS relapse. T cells from relapse
were cultured in the presence of PMA/ionomycin and the
expression of Tc-mip was analyzed by RT-PCR (Fig. 3 B).
In contrast to normal T cells, the expression of Tc-mip in
MCNS T cells was not altered by PMA/ionomycin stimu-
lation, suggesting that Tc-mip is involved in some signaling
pathway that might be dysregulated in MCNS.
Our recent investigations argue for an early commitment
of MCNS T cells along a Th2 phenotype (3). The identifi-
cation of a new gene up-regulated in this disease led us to
investigate its expression in polarized T cells along Th1 or
Th2 pathway. Under Th1 skewing conditions (T cells cul-
tured in the presence of IL-12 and anti–IL-4 antibody), the
expression of Tc-mip at both mRNA and protein levels was
little influenced, relatively to basal expression in resting T
cells (Fig. 3 C). By contrast, T cells incubated in the pres-
ence of IL-4 and anti–IL-12 antibody (Th2 conditions) ex-
hibited a strong induction of Tc-mip. This result constitutes
an additional element strengthening the Th2 bias in MCNS.
3-Specific Induction of Tc-mip in MCNS. We analyzed
by semi-quantitative RT-PCR the expression level of
c-mip and Tc-mip transcripts during the relapse and the re-
mission phases in nine patients who experienced a first epi-
sode of MCNS. The expression of Tc-mip mRNA was
increased during the relapse in the nine patients tested, as
compared with remission, whereas the eight normal sub-
jects exhibited very low levels of this transcript (Fig. 4 A).
In contrast, the expression level of the c-mip transcript was
very modest in both relapse and remission phases, whereas
it was highly expressed in normal subjects. The up-regula-
tion of Tc-mip mRNA appeared specific to MCNS since
four patients with membranous nephropathy, and a similar
range of proteinuria, exhibited a Tc-mip and c-mip mRNA
levels comparable to normal subjects.
We further studied whether the induction of Tc-mip
was restricted to a cell subset during the active phase of the
Figure 3. Differential expression of c-mip and Tc-mip in PBMC subsets. (A) Down-regulation of c-mip and Tc-mip by PMA/ionomycin. Resting
( ) and PMA/ionomycin-activated ( ) cells were isolated and analyzed for c-mip and Tc-mip transcript expression as described under Materials and
Methods. The expression of GAPDH was monitored in parallel. PBMC, peripheral blood mononuclear cells. BL, B lymphocyte. (B) Lack of down-
regulation of Tc-mip in MCNS T cells activated by PMA/ionomycin. MCNS T cells were activated as described above and then processed for Tc-mip
expression by semiquantitative RT-PCR. (C) Preferential induction of Tc-mip in Th2. Naive T cells were purified from blood umbilical cord, cultured
in the presence of PMA/Iono, or polarized under Th1 (IL12   anti-IL4) or Th2 (IL4   anti-IL12) skewing conditions and analyzed for c-mip/Tc-mip
and IL-4 mRNA expression by semiquantitative RT-PCR as described under Materials and Methods.T
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disease. We purified by immunomagnetic selection, the
CD4  and non-CD4  T cells species from PBMC of pa-
tients with relapse. The highest level of Tc-mip mRNA
was observed in the CD4  T cell subset (Fig. 4 B).
As we could not detect Tc-mip protein in normal
PBMC cells, we determined whether it was induced dur-
ing MCNS disease. We immunoblotted total protein ex-
tracts from PBMC of six patients in relapse. We detected a
major band of 75 kD specific of Tc-mip in patients with
MCNS relapse whereas the signal was undetectable in nor-
mal subjects (Fig. 4 C). In contrast, the expected 85 kD
band related to c-mip was weakly detectable in MCNS pa-
tients as well as in normal subjects.
Cellular distribution of Tc-mip was analyzed in PBMCs
from patients with MCNS. In relapse, we detected Tc-mip
in nuclear and cytoplasmic compartments, whereas its ex-
pression was restricted to the cytoplasm in remission (Fig. 4
D). In those samples, 20% of the PBMCs were Tc-mip
positive whereas no cellular staining was visualized in
PBMC from normal controls in accordance with the West-
ern blotting results (unpublished data).
4-Tc-mip Induces c-maf Nuclear Expression in Jurkat Cells.
Recently, we have shown that c-maf was strongly induced
in MCNS and shuttled between nuclear and cytoplasmic
compartments during the relapse and the remission phases,
respectively (unpublished data). As Tc-mip and c-maf are
mainly expressed in CD4 T cells, we examined whether
Tc-mip could influence c-maf expression. We transfected
Jurkat cells, which do not express either endogenous c-mip
or Tc-mip, with c-mip or Tc-mip expression vectors.
Transfection with Tc-mip induced c-maf expression at the
mRNA and protein level (Fig. 5 A, top panel), whereas
c-mip promoted a lower but significative induction of
c-maf relative to controls, the efficiency of transfection be-
ing similar (Fig. 5 A, bottom panel). Importantly, the ex-
pression pattern of the c-maf protein was radically different:
in cells overexpressing Tc-mip, c-maf was primarily detected
in nuclei (Fig. 5 B, top panel), whereas its expression was
much lower and mostly restricted to periphery of the cell in
c-mip transfected cells (Fig. 5 B, middle panel). The induc-
tion of c-maf and its nuclear localization in transfected cells
did not indicate that c-maf is transcriptionally active. To
Figure 4. Specific induction of Tc-mip in MCNS relapse. (A) RT-PCR analyses of Tc-mip mRNA expression. Nine patients with MCNS were
studied in relapse and in remission as well as eight normal subjects and four nephrotic patients with membranous nephropathy. The expression of
GAPDH was monitored in parallel, in order to control the initial amount of mRNA. The bottom panel shows quantification of the PCR bands in panel
A determined by using the Image Quant V 1.11 analysis software, after normalization against the corresponding GAPDH bands; (B) induction of Tc-mip
was higher in the CD4  T cell subset. Total RNA from CD4 , non-CD4  (nCD4) subsets was purified from PBMC of patients with MCNS relapse, as
described under Materials and Methods and analyzed for Tc-mip expression by RT-PCR. (C) Western blot analyses using anti-Tc-mip/c-mip antibody.
Total protein extracts (50  g) of PBMC from six patients in relapse and six normal subjects were tested for Tc-mip/c-mip expression; the specificity of
staining was demonstrated by the loss of signal upon preincubation of antibody with immunogenic peptide (asterisk). The blots were stripped and re-
probed with anti-actin antibodies; (D) immunostaining of PBMC of a pediatric patient with MCNS (4-yr-old, first relapse and remission). PBMCs were
purified, methanol fixed and incubated with anti-Tc-mip/c-mip antibody, as described under Materials and Methods ( 40, magnification).T
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address this question, we analyzed by EMSA experiments,
c-maf–dependent DNA binding activity in nuclear extracts
of Tc-mip–transfected Jurkat cells. We only detected a slow
migrating complex binding to MARE probe in Tc-mip
transfected Jurkat cells whereas no complex was visible in
c-mip transfected cells This band shift was specific since it
was not formed in the presence of mutant MARE oligonu-
cleotide (Fig. 5 C). Moreover, the specificity of DNA
binding was demonstrated by the loss of the band shift in
the presence of anti-c-maf polyclonal antibody, as reported
by others (12), suggesting that antibody competes c-maf for
binding to the Mare sequence. These results suggest that
Tc-mip induced a functional c-maf in Jurkat T cells.
Confocal fluorescence microscope analysis revealed that
the c-mip protein was restricted to peripheral area of trans-
fected cells, whereas Tc-mip was diffusely expressed, par-
ticularly in nuclear compartment (Fig. 5 D). Thus, Tc-mip
and c-maf display a similar distribution in nuclei and cyto-
plasmic compartments but we were not able to coimmuno-
precipitate both proteins. Altogether, these results suggest
that truncation of the PH domain affects the cellular distri-
bution of the Tc-mip protein, which might regulate the in-
duction and the cellular compartmentalization of c-maf.
5-Overexpression of Tc-mip Results in Differential Effects on
IL-4 and IFN-  Production. As c-maf is a transactivator of
the IL-4 gene (5, 13), the identification of Tc-mip as an
upstream inducer of c-maf led us to determine whether Tc-
mip could be able to activate the IL-4 gene. To that end,
we analyzed the effects of a transient transfection of Tc-mip
on IL-4 promoter activity in Jurkat cells. In unstimulated-
transfected Jurkat cells, no significant variation of the IL-4–
dependent CAT activity was detected after transfection
with Tc-mip (Fig. 6 A). When transfected Jurkat T cells
were stimulated with anti-CD3 antibody, Tc-mip and c-mip
Figure 5. Tc-Mip induces
c-maf nuclear expression. (A)
RT-PCR and Western blot anal-
yses for c-maf expression in Jur-
kat cells transfected with either
Tc-mip, c-mip, or empty vector,
as described under Materials and
Methods. (B) Top panel, immu-
nofluorescence detection of
c-maf in transfected Jurkat cells.
The data are representative of six
separate experiments. Bottom
panel, Western blotting of cyto-
solic extracts from transfected
cells, using anti-c-mip/Tc-mip
antibody. (C) c-maf DNA bind-
ing activity. EMSA analyses of
nuclear extracts (15  g) from Tc-
mip- (lane 1–3) and c-mip-
(Lane 4) transfected Jurkat cells.
The specificity of the band shift
(black arrow) was demonstrated
by the loss of DNA binding
when the mutant Mare (mt
Mare) was substituted to wild-
type Mare sequence (line 5) and
in the presence of anti-c-maf an-
tibody (right of the Fig. 3 C). (D)
Confocal imaging of Tc-mip and
c-mip after transient transfection
in Jurkat cells with respective ex-
pression vectors. This result is
representative of several cells in
four independent experiments.T
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induced a fourfold and twofold increase of Il-4 promoter
activity relative to control, respectively (Fig. 6 B).
As Tc-mip induces the expression of c-maf, we supposed
that these cells acquired a Th2 phenotype. To test this hy-
pothesis we analyzed in parallel IFN-  and IL-4 mRNA
expression, two reliable markers of Th1 and Th2 profile,
respectively. In unstimulated transfected T cells, Tc-mip,
and c-mip did not alter significantly the IL-4 and IFN- 
mRNA expressions, relative to controls (Fig. 5 B). Upon
stimulation with anti-CD3 antibody, IL-4 mRNA expres-
sion was considerably increased, whereas IFN-  mRNA
expression was sharply reduced in Tc-mip-overexpressing
cells (Fig. 6 B). By contrast, c-mip did not reduce IFN- 
mRNA, whereas the IL-4 mRNA was slightly increased
relative to Tc-mip–transfected cells. This result suggests
that signals emanating from TCR engagement provided
additional requirement for c-maf-mediated Th2 pathway
in which Tc-mip but not c-mip might play a potent role.
6-Overexpression of Tc-mip Is Associated with T Cell Activa-
tion and Cellular Redistribution of Cytoskeleton-associated
L-plastin. Our precedent results support the role of TCR ac-
tivation in c-maf signaling pathway, as it has been reported
previously (14), but upstream proteins involved in c-maf in-
duction remain unidentified. As Tc-mip behaves as a proxi-
mal inducer of c-maf expression, we wished to determine
whether Tc-mip could mimic TCR signaling. To test this
hypothesis, we analyzed the distribution of L-plastin, a cyto-
skeleton protein that is up-regulated in active MCNS dis-
ease (3). L-plastin is an actin bundling protein that plays an
important role in microspike and filopodia formation. It is
activated after costimulation via an accessory receptor such
as CD2 and CD28. Activation of l-plastin is required for full
T cell activation and stabilization of immunological synapse
by clustering receptors and bundling actin filaments at the T
cell/Ag presenting cell contact area (15, 16). We transfected
Jurkat T cells with Tc-mip and c-mip expression vectors
and 16 h later, cells were recovered from medium alone,
fixed and incubated with L-plastin monoclonal antibody. T
cells transfected with Tc-mip induced a cell clustering with
distribution changes of L-plastin that was relocalized in cy-
toplasmic zones facing the cell contact (Fig. 7 A, top panel),
whereas c-mip, transfected with a similar efficiency (Fig. 7
A, bottom panel), exhibited an homogeneously distribution
of L-plastin in the cytoplasm area. We conclude that over-
expression of Tc-mip promotes the cytoskeleton rearrange-
ment. To support this data, we analyze the status of Src pro-
tein tyrosine kinase, a proximal signaling protein that is
recruited early in T cell activation. Protein extracts from
Tc-mip, but not c-mip, overexpressed T cells displayed a
strong signal with anti-phospho-Src (Tyr 416; Fig. 7 B). To
assess whether this effect involved the PI3-kinase pathway,
we treated Tc-mip–transfected cells with wortmanin, a PI3-k
inhibitor. We found that cell clustering as well as the relo-
calization of L-plastin were not affected by wortmanin
treatment (Fig. 7 C). These results suggest that Tc-mip in-
duced T cell activation and cytoskeleton reorganization by a
mechanism independent of PI3 kinase activity.
Discussion
We isolated from T lymphocyte of patients with MCNS
a new signaling protein, Tc-mip, which induce T cell acti-
vation, cytoskeleton redistribution, and c-maf transcription
factor. Tc-mip corresponds to a truncated form of the pro-
tein c-mip, both proteins being produced by a single gene
through two alternative transcripts. The main difference
between these proteins is a deletion in Tc-mip of the NH2-
terminal part of a PH domain, which is fully functional in
c-mip. These two proteins display striking differences in
cellular expression and distribution, as well as in functional
characteristics.
The selective expression of Tc-mip in thymus and fetal
liver contrasts with its modest detection in normal periph-
eral T cells. Interestingly, the c-mip transcript is mostly ex-
pressed in mature PBMC and the fetal liver signal detected
with the common probe presumably reflects the contribu-
tion of Tc-mip. These data suggest that Tc-mip is ex-
pressed by normal lymphocyte precursors but this expres-
sion shuts down during maturation and differentiation
processes occurring in thymus and fetal liver.
Figure 6. Tc-Mip induces the transactivation of the IL-4 gene and in-
hibits the IFN-  expression in stimulated Jurkat T cells. (A) Jurkat T cells
were transiently cotransfected with the IL-4/CAT reporter vector and either
Tc-mip, c-mip, or empty vector. Cells were then incubated with medium
alone or with anti-OkT3 monoclonal antibody as described under Materials
and Methods. Data are expressed as fold induction of intracellular CAT
and represent the mean results of four independent experiments. (B) RT-
PCR of total RNA extracted using IL-4 and INF-  specific primers
(Table I). The expression of GAPDH was monitored in parallel.T
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We showed that Tc-mip is specifically expressed in
CD4  T cells in patients with MCNS and plays a driving
role in c-maf–mediated Th2 signaling pathway. Such find-
ings extend our previous data regarding the specific recruit-
ment of c-maf in MCNS (unpublished data). Conversely,
c-mip is mainly detectable in PBMCs of normal subjects
and exerts slight effects on c-maf expression that is re-
stricted to cytoplasmic compartment.
Under unstimulated conditions, c-mip and Tc-mip pro-
teins were weakly or not detected despite the basal expres-
sion of their respective transcripts, as reported for other genes
expressed in immune cells (17). Upon stimulation by phar-
macological agents that increase (Ca2 )i such as PMA/iono-
mycin, we observed a dramatic fall in Tc-mip and c-mip
mRNA levels. By contrast, these agents did not apparently
influence the expression of c-maf in similar culture condi-
tions of normal cells (18, 19), suggesting that regulation of
c-maf in physiological conditions is independent of Tc-mip.
It is likely that PMA/ionomycin activate PKC, which exerts
a negative regulatory role on Tc-mip/c-mip signaling path-
way as recently demonstrated for the PI3k/AKT pathway
(20). On the other hand, the stimulation by PMA/ionomy-
cin failed to induce a down-regulation of Tc-mip in MCNS
T cells, suggesting that alteration of this signaling pathway
contribute to T cell dysfunction in this disease.
Under Th skewing conditions, Tc-mip is preferentially
recruited in Th2 but not in Th1 cells. In addition c-maf is
induced in Tc-mip–transfected T cells and there is an in-
crease of IL-4 promoter activity. The IL-4 induction in
Tc-mip-, and to a lesser extent, in c-mip–overexpressing T
cells, was observed only after TCR engagement after stim-
ulation by the anti-CD3 antibody. These data suggest that
additional signals, stemming from TCR, are required for
the IL-4 induction by c-maf, as reported previously (14).
Intracellular molecules, known as cytosolic adaptor pro-
teins (CAPs) and lacking intrinsic enzymatic or transcrip-
tional activity, contain modular domains which serve to re-
cruit proteins to couple proximal events initiated by TCR
ligation with more distal signaling pathways. Tc-mip/
c-mip might fall into this CAP family as the first protein
identified so far, linking TCR proximal signaling to c-maf
transcription factor.
By comparison, NFATc-mediated Th2 signaling uses
apparently distinct pathway, involving the activation of lck
and the phosphactivation of the PH domain-containing
protein Itk/Emt, a T cell associated Tec kinase (21). As
matter of fact, Th2 development fails in lck-deficient T
cells (22). Nuclear localization of NFATc is sharply re-
duced in itk-deficient T cells upon stimulation by anti-
TCR/CD28 (23). However, activation of PKC with cal-
Figure 7. Tc-mip induces T cell activation and cytoskeleton reorganization by a PI3 kinase-independent mechanism. (A) Top panel, immunofluores-
cence detection of L-plastin in unstimulated Jurkat cells transfected with either Tc-mip, c-mip or empty vector. The data are representative of three
independent experiments. Bottom panel, Western blotting of cytosolic extracts from transfected cells, using anti–c-mip/Tc-mip antibody. (B) Western
blot analyses of protein extracts (50  g) from empty vector- (lane 1), c-mip- (lane 2), and Tc-mip- (lane 3) transfected Jurkat cells, using anti-phospho
Src antibody (Tyr 416). (C) Pharmacologic inhibitors of PI3-K did not inhibit redistribution of cytoskeleton-associated L-plastin. Jurkat T cells trans-
fected with Tc-mip and wortmanin (100 nM) was added to medium culture, six hours following transfection and left overnight. This result was repro-
duced in three independent experiments.T
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cium ionophore restores NFATc-mediated IL-4 expres-
sion. Importantly, Itk does not exhibit any influence on
Th1 cytokines (24). These data fundamentally differentiate
Itk/Emt from Tc-mip by at least two aspects: (a) Tc-mip
bypasses the requirement for calcium signaling; (b) Tc-mip
induces c-maf and represses the IFN-  expression. Never-
theless, whether the down-regulation of IFN-  is a direct
effect of Tc-mip or a consequence of the induction of c-maf
remains to be clarified.
PH domain-containing proteins are members of a large
family involved in cellular signaling (25, 26, 27). The con-
sensus sequence of the PH domains is weak but they share
similar core   sandwich structure (28). The PH domains
comprise  100 amino acids, likely to recruit molecules to
the membrane by specific interactions with phosphoinositide
lipids (28). These interactions might contribute to the attach-
ment of the plasma membrane to the cytoskeleton through
lipid–protein and protein–protein interactions leading to a
regulation of the cytoskeleton organization (29). We showed
here that Tc-mip partially mimics TCR signaling and in-
duced T cell clustering and refolding of the cytoskeleton
protein L-plastin, independently of PI3 kinase pathway.
The truncation of the PH domain of Tc-mip is associ-
ated with a nuclear location of the protein. This suggests
that the PH domain of c-mip acts cooperatively with
membrane phosphoinositides to cluster c-mip at and near
the plasma membrane. The nuclear translocation of Tc-
mip might result from the alteration of the   sheet struc-
ture present in the phosphoinositide-binding module of the
PH domain of c-mip, as previously shown for other PH
domain-containing proteins (29–31).
The inhibitory role of the PH domain on cellular signal-
ing has been documented for other proteins. The PH do-
main of the guanine nucleotide exchange factors (GEFs)
Vav-1 acts as a negative, intramolecular regulator of Dbl
homology (DH) domain function. Mutations in the PH
domain alters the phosphoinositide binding of Vav-1 and
induces an increase in GEF activity (32). In addition, a Vav
variant, lacking the PH domain, induces JNK activation
leading to cytoskeletal reorganization (33). As other exam-
ples, deletion of the PH domain of the protein kinase D
(PKD) or point mutation in PH domain from Bruton’s ty-
rosine kinase (BTK), increased kinase activities (34, 35).
Alterations of the PH domain have also been associated
with several human disease: (a) a point mutation in the PH
domain of Btk is associated with X-linked agammaglobuli-
naemia (36); (b) alterations in the DH-PH domain of proteins
such as Ost, Lfc, Dbs, or the FGD-1 gene are implicated in
human oncogenesis and developmental disorders (37–40).
Inasmuch that c-mip constitutes the normal protein iso-
form in T lymphocytes of normal subjects, the occurrence
of Tc-mip at high level in MCNS patients allows impor-
tant regulatory changes in the putative signaling pathway.
Truncation of the PH domain might suppress the anchor-
age of Tc-mip to membrane-phosphoinositides, precluding
proximal interactions, which could be negatively regulate
T-cmip. Nevertheless, Tc-mip conserves other domains al-
lowing its interactions with downstream signaling mole-
cules. After TCR stimulation, Tc-mip up-regulates the ac-
tivation cascades that ultimately induce c-maf and affect its
cytokine repertoire.
In conclusion, we identified in this study a new protein,
Tc-mip, which is specifically recruited during MCNS. We
showed that Tc-mip links TCR-mediated signal to the ac-
tivation of c-maf Th2 specific factor. The presence of a
truncated PH domain allows a nuclear translocation of the
protein, which promote a high c-maf expression level in
MCNS patients. It also gives additional evidence regarding
the inhibitory function of the PH domain on protein activ-
ity and its critical role on protein localization. Finally, it
gives strong support to the potential involvement of un-
known alternative species of transcripts in human diseases.
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